ES403317A1 - Therapeutic composition - Google Patents
Therapeutic compositionInfo
- Publication number
- ES403317A1 ES403317A1 ES403317A ES403317A ES403317A1 ES 403317 A1 ES403317 A1 ES 403317A1 ES 403317 A ES403317 A ES 403317A ES 403317 A ES403317 A ES 403317A ES 403317 A1 ES403317 A1 ES 403317A1
- Authority
- ES
- Spain
- Prior art keywords
- therapeutic composition
- triiodothyroacetic acid
- appropriate
- constituents
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Procedure for the solubilization of therapeutic compositions based on L-thyroxine and 3-3-5-triiodothyroacetic acid, associated with a diffusion factor such as hyaluronidase, characterized in that it consists in dissolving the three aforementioned constituents of the composition in a vehicle appropriate, at the same time solvent for said active constituents, and in particular 3-3-5-triiodothyroacetic acid, and miscible with water, adding an appropriate wetting agent. (Machine-translation by Google Translate, not legally binding)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7120183A FR2139748B1 (en) | 1971-06-03 | 1971-06-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES403317A1 true ES403317A1 (en) | 1976-04-01 |
Family
ID=9078067
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES403317A Expired ES403317A1 (en) | 1971-06-03 | 1972-05-30 | Therapeutic composition |
Country Status (8)
Country | Link |
---|---|
JP (1) | JPS5212779B1 (en) |
BE (1) | BE784267A (en) |
CA (1) | CA982477A (en) |
CH (1) | CH572744A5 (en) |
DE (1) | DE2226927A1 (en) |
ES (1) | ES403317A1 (en) |
FR (1) | FR2139748B1 (en) |
GB (1) | GB1354263A (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH622703A5 (en) * | 1976-06-10 | 1981-04-30 | Berema Sa | Therapeutic compositions for treating deposits of excess fat and infiltrates causing cellulite |
US4525359A (en) * | 1982-12-10 | 1985-06-25 | Greenway Frank L Iii | Treatment for selective weight control |
DE69630380T8 (en) * | 1995-06-07 | 2009-08-06 | Lavin, Thomas N., Dr. | NEW USES OF THYROID HORMONES OR THYROIDHORMONE SIMILAR COMPOUNDS |
US6380255B1 (en) | 1995-06-07 | 2002-04-30 | Karo Bio Ab | Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds |
GB2457710A (en) * | 2008-02-25 | 2009-08-26 | Andrew Nicolaou | Thyroxine and its use in weight loss and obesity treatment |
-
1971
- 1971-06-03 FR FR7120183A patent/FR2139748B1/fr not_active Expired
-
1972
- 1972-05-25 CH CH770672A patent/CH572744A5/xx not_active IP Right Cessation
- 1972-05-30 ES ES403317A patent/ES403317A1/en not_active Expired
- 1972-06-01 BE BE784267A patent/BE784267A/en unknown
- 1972-06-02 CA CA143,782A patent/CA982477A/en not_active Expired
- 1972-06-02 DE DE2226927A patent/DE2226927A1/en active Pending
- 1972-06-02 GB GB2593172A patent/GB1354263A/en not_active Expired
- 1972-06-03 JP JP47055562A patent/JPS5212779B1/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
BE784267A (en) | 1972-12-01 |
FR2139748B1 (en) | 1974-08-30 |
CA982477A (en) | 1976-01-27 |
GB1354263A (en) | 1974-06-05 |
JPS5212779B1 (en) | 1977-04-09 |
DE2226927A1 (en) | 1973-01-18 |
CH572744A5 (en) | 1976-02-27 |
FR2139748A1 (en) | 1973-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES396288A1 (en) | Light protection agent for cosmetic purposes | |
ES296969A1 (en) | Shellac tablet coating compositions and methods of preparation | |
ES403317A1 (en) | Therapeutic composition | |
ES294061A1 (en) | Method for the concentration of thixotropic compositions (Machine-translation by Google Translate, not legally binding) | |
ES302412A1 (en) | Herbicidal composition and method | |
ES376357A1 (en) | S-alkyl-(methylhexahydro-1h-azepine)-1-carbothiolates | |
ES349900A1 (en) | A procedure for the preparation of pharmaceutical compositions of chlorosured steroids. (Machine-translation by Google Translate, not legally binding) | |
Fletcher | The development of small-scale farming in New South Wales (excluding Norfolk Island), 1787 to 1803 | |
ES256730A1 (en) | An apparatus for agricultural uses (Machine-translation by Google Translate, not legally binding) | |
FR2282M (en) | 6 alpha-chloro-16 alpha-methyl-progesterone useful in particular as an anti-estrogenic agent. | |
BE606205A (en) | New pharmaceutical compositions comprising 5-nitro-8-hydroxy-quinoline as well as its halogenated derivatives in position 7. | |
ES260812A1 (en) | Improvements in the obtaining of antichriptogram compositions (Machine-translation by Google Translate, not legally binding) | |
ES78747U (en) | Rotating platform for gastronomic services (Machine-translation by Google Translate, not legally binding) | |
FR1636M (en) | Injectable bihormonal composition, useful in particular as an anti-abortion drug. | |
ES268307A3 (en) | Improvements introduced in the construction of auto vehicle frames (Machine-translation by Google Translate, not legally binding) | |
ES101717U (en) | Perfected game (Machine-translation by Google Translate, not legally binding) | |
ES349821A1 (en) | Improvements in or relating to Agricultural Compositions | |
ES149639U (en) | Skill game (Machine-translation by Google Translate, not legally binding) | |
ES156499Y (en) | PERFECTED COMPOSITION GAME. | |
ES346611A1 (en) | A procedure for preparing a pharmaceutical composition intended for the treatment of broncoconstriction and hypertension. (Machine-translation by Google Translate, not legally binding) | |
ES157775U (en) | Perfected therapeutic suppository. (Machine-translation by Google Translate, not legally binding) | |
ES364913A1 (en) | Procedure for stabilizing a composition of a polyolefin (Machine-translation by Google Translate, not legally binding) | |
ES360073A1 (en) | Procedure for the preparation of vasodilator compositions. (Machine-translation by Google Translate, not legally binding) | |
ES336947A1 (en) | Improvements introduced in the preparation of asbestos compositions. (Machine-translation by Google Translate, not legally binding) | |
ES409205A1 (en) | A procedure for the preparation of a 1,2 alpha-methylen -6,7 alpha-dihalometilen-20-espirox-4-eno 3-oxygenate. (Machine-translation by Google Translate, not legally binding) |